ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026
Treatment with the Nox1/4 inhibitor Setanaxib ameliorates cardiac function in mouse models of Duchenne muscular dystrophy.
Rui Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.